Chemoinformaics analysis of 2,4,6-Tri-O-galloyl-D-glucose
| Molecular Weight | 636.471 | nRot | 11 |
| Heavy Atom Molecular Weight | 612.279 | nRig | 18 |
| Exact Molecular Weight | 636.096 | nRing | 3 |
| Solubility: LogS | -4.82 | nHRing | 0 |
| Solubility: LogP | 2.788 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 69 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 45 | No. of Aromatic Carbocycles | 3 |
| nHetero | 18 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 27 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 18 |
| No. of Oxygen atom | 18 | No. of Arom Bond | 18 |
| nHA | 18 | APOL | 75.529 |
| nHD | 11 | BPOL | 32.757 |
| QED | 0.586 |
| Synth | 2.059 |
| Natural Product Likeliness | 0.591 |
| NR-PPAR-gamma | 0.016 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.096 |
| Pgp-sub | 0 |
| HIA | 0.005 |
| CACO-2 | -4.715 |
| MDCK | 0.0000175 |
| BBB | 0.331 |
| PPB | 0.949814 |
| VDSS | 1.148 |
| FU | 0.028076 |
| CYP1A2-inh | 0.965 |
| CYP1A2-sub | 0.485 |
| CYP2c19-inh | 0.462 |
| CYP2c19-sub | 0.117 |
| CYP2c9-inh | 0.474 |
| CYP2c9-sub | 0.493 |
| CYP2d6-inh | 0.057 |
| CYP2d6-sub | 0.493 |
| CYP3a4-inh | 0.526 |
| CYP3a4-sub | 0.17 |
| CL | 3.87 |
| T12 | 0.069 |
| hERG | 0.035 |
| Ames | 0.938 |
| ROA | 0.564 |
| SkinSen | 0.141 |
| Carcinogencity | 0.927 |
| EI | 0.982 |
| Respiratory | 0.379 |
| NR-Aromatase | 0.841 |
| Antiviral | Yes |
| Prediction | 0.655249 |